After reviewing and summarizing the literature, we found no clear association between the KRAS-LCS6 genotype and overall or progression-free survival among colorectal cancer patients, even after conducting subgroup analysis by stage and anti-EGFR treatment status. This evidence concerns the gene KRAS and colorectal cancer.